Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje
Iingcaphuno zeStock zeenkampani ezingama-71229 ngexesha langempela.
Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje

Iingcaphuno zempahla

Imali icatshulwa kwi-intanethi

Imbali icatshulwa ngemali

Imali yerhwebo yemali

Izabelo zeStock

Inzuzo kwizabelo zenkampani

Iingxelo zemali

Izabelo zezabelo zeenkampani. Kuphi utyalo mali?

Imbuyekezo Regeneron Pharmaceuticals, Inc.

Ingxelo kwimiphumo yemali yenkampani Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. ingeniso yonyaka ka-2024. Uphi Regeneron Pharmaceuticals, Inc. ukupapasha iingxelo zezimali?
Yongeza kumajethijethi
Ukongezwa kumajethi

Regeneron Pharmaceuticals, Inc. ingeniso iyonke, umvuzo wengeniso kunye nentshukumo yotshintsho kwi Euro namhlanje

Regeneron Pharmaceuticals, Inc. imali eseleyo yanamhlanje 2 528 700 000 €. Izinto eziguquliweyo ze Regeneron Pharmaceuticals, Inc. ingeniso iyonke inyuswe nge 292 500 000 € ukusuka kwixesha lokugqibela lokunika ingxelo. Izinto eziguquliweyo ze Regeneron Pharmaceuticals, Inc. umvuzo omninzi wehle -34 000 000 €. Uvavanyo lwezinto eziguqulweyo ze Regeneron Pharmaceuticals, Inc. ingeniso yonke yenziwa ngokuthelekisa ingxelo yangaphambili. Regeneron Pharmaceuticals, Inc. itshathi yengxelo yezezimali kwi-intanethi. Igrafu yemali ye Regeneron Pharmaceuticals, Inc. ibonisa imeko ekwi-Intanethi: ingeniso iyonke, ingeniso iyonke, ii-asethi zizonke. Itshathi yengxelo yemali kwiwebhusayithi yethu ibonisa ulwazi ngemihla 30/06/2020 ukuya 31/03/2021.

Umhla weNgxelo Ingeniso yonke
Imali engenayo ibalwa ngokuphindaphinda ubuninzi beempahla ezithengiswa ngentengo yempahla.
kwaye Utshintsho (%)
Ukuthelekiswa kwengxelo yonyaka ngekota ngekota yonyaka odlulileyo.
Imali engenayo
Imali engenayo yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo.
kwaye Utshintsho (%)
Ukuthelekiswa kwengxelo yonyaka ngekota ngekota yonyaka odlulileyo.
31/03/2021 2 346 555 210.30 € - 1 034 871 028.80 € -
31/12/2020 2 075 124 277.80 € - 1 066 421 974.80 € -
30/09/2020 2 128 760 886 € - 781 442 694.90 € -
30/06/2020 1 811 395 488 € - 832 666 583.70 € -
Bonisa:
Ukuze

Umbiko wezezimali Regeneron Pharmaceuticals, Inc., ishedyuli

Imihla yokugqibela ka Regeneron Pharmaceuticals, Inc. ezikhoyo kwi-intanethi: 30/06/2020, 31/12/2020, 31/03/2021. Imihla yeengxelo zemali ilawulwa ngokuqinileyo ngumthetho kunye neengxelo zezemali. Umhla wamva wengxelo yezezimali Regeneron Pharmaceuticals, Inc. yi 31/03/2021. Inzuzo eninzi Regeneron Pharmaceuticals, Inc. yinzuzo eyenziwa yinkampani emva kokunciphisa iindleko zokuvelisa nokuthengisa iimveliso zayo kunye / okanye indleko yokubonelela ngeenkonzo zayo. Inzuzo eninzi Regeneron Pharmaceuticals, Inc. na 1 477 800 000 €

Imihla yeengxelo zezimali Regeneron Pharmaceuticals, Inc.

Ingeniso yokusebenza Regeneron Pharmaceuticals, Inc. yinkalo yokuphendula eyenza umlinganiselo wenzuzo efunyenwe kwimisebenzi yoshishino, emva kokunciphisa iindleko zokusebenza, ezifana nomvuzo, ukwehla kwexabiso kunye neendleko zeempahla ezithengiswayo. Ingeniso yokusebenza Regeneron Pharmaceuticals, Inc. na 1 112 700 000 € Imali engenayo Regeneron Pharmaceuticals, Inc. yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo. Imali engenayo Regeneron Pharmaceuticals, Inc. na 1 115 200 000 € Iindleko zokusebenza Regeneron Pharmaceuticals, Inc. ziindleko ezithatha ishishini ngenxa yokuqhuba imisebenzi yayo yesiqhelo. Iindleko zokusebenza Regeneron Pharmaceuticals, Inc. na 1 416 000 000 €

Iimpahla zangoku Regeneron Pharmaceuticals, Inc. ziyimpahla yamaphepha ebhalansi ebonisa ukubaluleka kwazo zonke i-asethi ezingatshintshwa zibe yimali emnyakeni owodwa. Iimpahla zangoku Regeneron Pharmaceuticals, Inc. na 10 055 100 000 € Imali ekhoyo Regeneron Pharmaceuticals, Inc. yimali yonke imali egcinwe yinkampani ngosuku lombiko. Imali ekhoyo Regeneron Pharmaceuticals, Inc. na 1 437 900 000 € Ubulungisa Regeneron Pharmaceuticals, Inc. bubungakanani bempahla yonke yomnini emva kokususa amatyala onke kwiimpahla ezipheleleyo. Ubulungisa Regeneron Pharmaceuticals, Inc. na 11 977 000 000 €

  31/03/2021 31/12/2020 30/09/2020 30/06/2020
Inzuzo eninzi
Inzuzo eninzi yinzuzo eyenziwa yinkampani emva kokunciphisa iindleko zokuvelisa nokuthengisa iimveliso zayo kunye / okanye indleko yokubonelela ngeenkonzo zayo.
1 371 352 588.20 € 1 056 585 503.40 € 1 239 209 802.60 € 885 746 410.50 €
Ixabiso lentengo
Ixabiso lilonke iindleko zemveliso kunye nokuhanjiswa kwemveliso kunye neenkonzo zenkampani.
975 202 622.10 € 1 018 538 774.40 € 889 551 083.40 € 925 649 077.50 €
Ingeniso yonke
Imali engenayo ibalwa ngokuphindaphinda ubuninzi beempahla ezithengiswa ngentengo yempahla.
2 346 555 210.30 € 2 075 124 277.80 € 2 128 760 886 € 1 811 395 488 €
Ingeniso yokusebenza
Ingeniso yokusebenza iyimali evela kwingqesho yenkampani. Umzekelo, umthengisi wenza iholo ngenjongo yokuthengiswa kweempahla, kwaye ugqirha uyafumana inzuzo kwiinkonzo zonyango azinikezelayo.
- - - -
Ingeniso yokusebenza
Ingeniso yokusebenza yinkalo yokuphendula eyenza umlinganiselo wenzuzo efunyenwe kwimisebenzi yoshishino, emva kokunciphisa iindleko zokusebenza, ezifana nomvuzo, ukwehla kwexabiso kunye neendleko zeempahla ezithengiswayo.
1 032 551 106.30 € 821 530 955.70 € 977 244 153.90 € 609 118 851.60 €
Imali engenayo
Imali engenayo yimali yengeniso yenkampani ngaphandle kweendleko zeempahla ezithengiswayo, iindleko kunye neerhafu ngexesha lokunika ingxelo.
1 034 871 028.80 € 1 066 421 974.80 € 781 442 694.90 € 832 666 583.70 €
Iindleko zeR & D
Iindleko zophando nophuhliso - iindleko zophando ukuphucula iimveliso kunye neenkqubo okanye ukuphuhlisa iimveliso kunye nemigaqo emitsha.
- - - -
Iindleko zokusebenza
Iindleko zokusebenza ziindleko ezithatha ishishini ngenxa yokuqhuba imisebenzi yayo yesiqhelo.
1 314 004 104 € 1 253 593 322.10 € 1 151 516 732.10 € 1 202 276 636.40 €
Iimpahla zangoku
Iimpahla zangoku ziyimpahla yamaphepha ebhalansi ebonisa ukubaluleka kwazo zonke i-asethi ezingatshintshwa zibe yimali emnyakeni owodwa.
9 330 821 091.90 € 9 074 701 647.90 € 8 442 290 774.40 € 7 294 021 933.80 €
Ixabiso lilonke
Inani elipheleleyo leempahla lilingana nemali epheleleyo yemali yentlangano, amanqaku amatyala kunye nempahla ebonakalayo.
16 492 050 661.80 € 15 927 010 337.70 € 14 925 453 396 € 13 389 386 310.30 €
Imali ekhoyo
Imali ekhoyo yimali yonke imali egcinwe yinkampani ngosuku lombiko.
1 334 326 625.10 € 2 035 685 595.30 € 1 459 695 237 € 1 848 699 841.80 €
Ityala langoku
Ithuba langoku liyinxalenye yetyala elihlawulelwa kunyaka (iinyanga ezili-12) kwaye luboniswe njengemfanelo ekhoyo kunye nenxalenye yemali esebenzayo.
- - - -
Iyonke imali
Ingqikithi yemali yintlawulo yemali yonke inkampani enayo kwiingxelo zayo, kubandakanywa imali encinci kunye nemali egcinwe ebhankini.
- - - -
Ityala elipheleleyo
Iityala ezipheleleyo zidibeneyo zetyala elifutshane kunye nexesha elide. Iimali ezifutshane zesikhashana zizo kufuneka zibuyiselwe ngaphakathi konyaka. Ithuba lexesha elide liquka iimeko zonke ezimele zihlawulwe emva konyaka omnye.
- - - -
Umlinganiselo weetyala
Ixabiso elipheleleyo lexabiso lemali lilonke lixabiso lemali elibonisa ipesenti yeefayili zeenkampani ezimele njengetyala.
- - - -
Ubulungisa
Ubulungisa bubungakanani bempahla yonke yomnini emva kokususa amatyala onke kwiimpahla ezipheleleyo.
11 114 284 713 € 10 231 136 615.70 € 9 396 150 109.50 € 8 404 986 420.60 €
Ukuhamba kwemali
Ukuhamba kwemali yintlawulo enemali yemali kunye nokulingana kwemali ejikelezayo kwintlangano.
- - - -

Ingxelo yemali yakutshanje kwingeniso ye Regeneron Pharmaceuticals, Inc. yayingu-31/03/2021. Ngokweengxelo zamuva malunga neziphumo zezimali ze-Regeneron Pharmaceuticals, Inc., imali engenayo ye-Regeneron Pharmaceuticals, Inc. yayingu-2 346 555 210.30 Euro kwaye yaguqulwa ibe yi-0% ngokumalunga nomnyaka odlulileyo. Inzuzo yentlawulo ye Regeneron Pharmaceuticals, Inc. kwikota yokugqibela yayingu-1 034 871 028.80 €, inzuzo yentengo ishintshwe ngu-0% xa kuthelekiswa nomnyaka odlulileyo.

Iindleko zezabelo Regeneron Pharmaceuticals, Inc.

YezeMali Regeneron Pharmaceuticals, Inc.